Coccidioidomycosis Collaborative Research Centers — RFA-AI-27-012
Supports translational vaccine teams targeting valley fever through collaborative centers.
The National Institute of Allergy and Infectious Diseases (NIAID) issued RFA-AI-27-012 on May 4, 2026, to establish Coccidioidomycosis Collaborative Research Centers (CCRCs) — a new initiative funding highly collaborative, multi-disciplinary teams to conduct translational and clinical research in support of a Valley fever vaccine. Coccidioidomycosis, commonly called Valley fever, is a fungal infec…
Coccidioidomycosis (Valley fever) vaccine development — translational and clinical research aligned with NIAID's Strategic Plan.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIAID
All grants from this funder →NIAID Investigator-Initiated P01
🇺🇸NIAID · United States
Supports investigator-led infectious disease and immunology multi-project teams under NIAID.
Impact of Initial Influenza Exposure on Immunity in Infants — RFA-AI-27-019
NIAID · United States
Supports longitudinal infant influenza immunity studies to guide next-generation vaccine design.
Tuberculosis Research Advancement Centers (TRACs) — RFA-AI-27-016
🇺🇸NIAID · United States
Supports tuberculosis research centers through shared resources and interdisciplinary teams.
Similar grants
Browse the directory →
Governor's University Research Initiative
🇺🇸Texas EDT · United States
Funds Texas public universities to recruit nationally recognized scientific leaders and strengthen talent pipelines.
Cancer Research KI-Mayo Clinic CCC Synergy Grants
🇺🇸MCCCC & CRKI · Global / Multinational
Funds Mayo Clinic and Karolinska Institutet teams researching early cancer detection.
CPRIT Scholars — Recruitment of Rising Stars
🇺🇸CPRIT · United States
Funds Texas universities attracting mid-career cancer talent and strengthening high-quality oncology groups.
NIH CRP Commercialization Readiness Pilot
🇺🇸NIH SEED · United States
Offers late stage commercialization readiness support through NIH CRP for small firms advancing biomedical health solutions.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
🇺🇸NIH · United States
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
CPRIT Scholars — Recruitment of Established Investigators
🇺🇸CPRIT · United States
Funds Texas universities to recruit established cancer researchers and build strong senior leadership labs.